PAMPHLET
BehavioralElectronic version of pamphlet with comprehensive and up-to-date content on both pharmacologic and non-pharmacologic pain relief options during labour.
NCT Number: NCT07437703
The goal of this clinical trial is to investigate whether a structured educational video improves outcomes related to fear of birth and patient preparedness for pregnant adults who are planning to labour.
The primary objective is to evaluate whether an educational video can reduce fear of childbirth more effectively than a pamphlet.
Patients will complete a baseline questionnaire assessing their knowledge of labour pain relief options and their current fear of childbirth. The control group will be provided an electronic version of a pamphlet while the intervention group will watch an educational video outlining pharmacologic and non-pharmacologic options for labour pain relief. Immediately after the intervention, all participants will complete the same questionnaire to assess changes in fear and knowledge.
Trial opening soon.
Get Notified19 year and older
Female
Interventional
Not applicable
Study Design
The study will employ a randomized controlled trial design. Participants will be randomly assigned to one of two parallel arms: (1) a written pamphlet or (2) an intervention (7-minute educational video).
On the study day, all participants will complete a baseline questionnaire assessing their knowledge of labour pain relief options and their current fear of childbirth. Following informed consent, participants in the control group will be provided an electronic version of the pamphlet; those in the intervention group will watch the video. Immediately after the intervention, all participants will complete the same questionnaires to assess changes in fear and knowledge.
Participant Selection
Participants will be recruited during their routine prenatal appointments at antenatal clinics affiliated with this hospital. Every eligible patient will be invited to participate.
Inclusion criteria
Exclusion criteria
Recruitment
Recruitment will occur at prenatal interactions using multiple methods:
Randomization Participants will be randomized in a 1:1 ratio to either the intervention group (educational video) or the control group (written pamphlet). Allocation concealment will be preserved by randomizing the allocation table within REDCap, which will remain hidden from study personnel during the randomization process. Group assignment will be revealed only after participants have completed the baseline assessment and have been enrolled in the study.
Follow-up Questionnaires Follow-up will be conducted two weeks after their estimated due date (EDD). If the follow-up questionnaire is incomplete, one email follow-up reminder will be sent 2-weeks later (at 4-weeks post EDD).
Sample Size Calculation The primary outcome of this study is the change in fear of birth, measured using a validated 2-item Visual Analog Scale (VAS), with each item scored from 0 to 100 and averaged. To detect a 10-point difference with 90% power and a two-sided alpha of 0.05, we estimate that a total of 88 participants (44 per group) are needed. To account for an anticipated attrition rate, we plan to recruit a total of 100 participants (50 per group). This sample size will ensure the study is adequately powered to assess the effectiveness of the educational video in reducing fear of birth compared to standard pamphlet-based education.
Analysis Plan All data will be analyzed using Stata 13.1. P<0.05 will be considered significant. Normally distributed continuous and count variables will be compared using paired t-tests. Ordinal/categorical variables will be analyzed with t-tests, and binary categorial variables (yes/no) will be analyzed using Fisher's exact or Chi-Square tests.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electronic version of pamphlet with comprehensive and up-to-date content on both pharmacologic and non-pharmacologic pain relief options during labour.
An educational video featuring anesthesiologists explaining both pharmacologic and non-pharmacologic pain relief options
Time frame: From enrollment to end of post-intervention questionnaire (same day)
The primary outcome is the change in fear of birth (FOB), as assessed immediately after reviewing the educational material using a two-item visual analog scale. The FOB total score is derived by calculating the average of the two items that assess fear and worry regarding the upcoming birth, each ranging from 0 to 100, with higher scores indicating higher FOB.
Time frame: From enrollment to end of post-intervention questionnaire (same day)
Time frame: From enrollment to end of post-intervention questionnaire (same day)
Time frame: From enrollment to end of follow-up (2 weeks post estimated delivery date)
Time frame: From enrollment to end of follow-up (2 weeks post estimated delivery date)
Contact information is provided by the study sponsor or research team.
Michelle Mozel, MSc
CONTACT
Susan M Lee, MD
CONTACT
Fraser Health
Other
Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, a Randomized Controlled Trial
Acronym: LOVE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07378449
Labor Pain, Labour Pain
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07202221
Labor Pain, Labour Pain
London, United Kingdom
View Trial DetailsNCT07096661
Adults, Chronic Pain
Bournemouth, United Kingdom
View Trial DetailsNCT06214585
Body Temperature Changes, Cold Therapy
Bharatpur, Bagmati, Nepal
View Trial Details